The Neuro-Oncology Program at UPMC Children’s Hospital is at the center of finding new and improved treatments for pediatric brain and nervous system cancers. As one of the leading sites in the United States for childhood neurologic cancer research and clinical studies, UPMC Children’s brain tumor patients have access to clinical trials of the newest brain and spine cancer treatments.
Clinicians and researchers in Hematology, Oncology, and Neuro-Oncology develop research models that seek to learn why some children develop cancers; create innovative cancer treatments; and find cures for child with cancers.
Insights gained through this research enable healthcare providers to bring new treatment strategies from the lab to clinical trials for many types of brain tumors, including high-grade glioma studies lead by CBTTC PI Dr. Ian Pollack; making a powerful impact on the quality of life of childhood brain cancer patients.
Kimberly Diamond | Clinical Research Coordinatorhttps://www.chp.edu/
Sameer Agnihotri, PhD
Sameer Agnihotri, PhD, joined the faculty of the Department of Neurological Surgery at UPMC Children’s Hospital of Pittsburgh in November of 2016.Dr. Agnihotri graduated from the University of Toronto in 2005 with a bachelor of science honors degree in biology, specializing in genetics. He
Clayton A. Wiley, MD, PhD
Dr. Wiley's research concentrates on the pathogenesis of neurodegenerative diseases and in particular on viral and age induced nervous system diseases. Viruses damage the nervous system either by direct infection of neural cells or by secondary effects of an immune response. In recent years
Gary Kohanbash, PhD
Gary Kohanbash, PhD, joined the faculty of the Department of Neurological Surgery at UPMC Children’s Hospital of Pittsburgh in January of 2017.Dr. Kohanbash graduated from the University of Pittsburgh in 2007 with a bachelor of science honors degree in neuroscience, specializing in neurode